# ARA-290 for sarcoidosis small nerve fiber loss: 28-day trial

Source: https://pepvault.app/research/ara-290-dahan-2013

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [ARA-290](https://pepvault.app/research#ara-290)

Randomized trial · people

# ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This is a controlled human trial in which ARA-290 improved nerve symptoms and corneal nerve fiber density in sarcoidosis over 28 days.

- **Kind:** Randomized trial
- **Studied in:** People
- **Published:** 2013
- **Journal:** Mol Med

## What they tested

The team tested whether daily ARA-290 could ease symptoms in people with sarcoidosis who have small nerve fiber loss and damage (SNFLD).

## How the study was done

A blinded, randomized, placebo-controlled trial in patients with sarcoidosis and documented SNFLD. They got either ARA-290 or a placebo (a dummy shot) as a daily injection under the skin for 28 days.

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Patients on ARA-290 had a significant improvement in neuropathic (nerve-related) symptoms they reported themselves, compared with placebo. ARA-290 was also linked to a significant rise in the density of small nerve fibers in the cornea, the clear front layer of the eye. Patients also showed changes in how their skin sensed temperature. They walked farther on the 6-minute walk test, a measure of exercise capacity.

## What it doesn’t show

Treatment lasted only 28 days, so the trial doesn't show whether the changes last or hold up over a longer course. It studied only sarcoidosis-related nerve fiber loss. The authors' view that ARA-290 could change the course of the disease is a suggestion, not something this trial tested.

## The paper

Dahan et al. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Mol Med. 2013.

- [PubMed (PMID 24136731)](https://pubmed.ncbi.nlm.nih.gov/24136731/)
- [The paper (DOI 10.2119/molmed.2013.00122)](https://doi.org/10.2119/molmed.2013.00122)

## The compound

- [ARA-290: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017)
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on ARA-290

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017) Randomized trial · people · 2017
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012) Randomized trial · people · 2012
- [ARA-290 eased nerve-injury pain for up to 20 weeks in rats](https://pepvault.app/research/ara-290-swartjes-2014) Animal study · rats · 2014
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017)
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

## The library

- [ARA-290](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
